Somanetics Corporation (NASDAQ: SMTS) focuses on developing, manufacturing and marketing the INVOS® Cerebral/Somatic Oximeter. This non-invasive patient monitoring system constantly measures changes in the blood oxygen levels in patients with or at risk for restricted blood flow. The INVOS System also provides the information necessary to identify oxygen imbalances in tissues beneath the sensor, allowing medical professionals to take corrective action. For further information, visit the Company’s web site at www.somanetics.com.
- 17 years ago
QualityStocks
Somanetics Corporation (NASDAQ: SMTS)
Tags Rodman & Renshaw
Related Post
-
D-Wave Quantum Inc. (NYSE: QBTS) Partners with Yonsei University and Incheon City to Advance Quantum Adoption in South Korea
The three parties signed an MOU focusing on research collaboration, education, and commercial use case…
-
Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Positioning Itself as a Premier Nevada Mine Developer and Explorer in Today’s Gold Market
Walker Lane is one of the hottest exploration area plays in the United States and…
-
AI Tools Aren’t Enough: Why Smart Brands Still Need Agencies Like ONAR’s
Meta’s new ad automation tools aren’t a silver bullet for brands; agencies still play a…